206 related articles for article (PubMed ID: 15456252)
1. Identification and characterization of small molecule inhibitors of the calcium-dependent S100B-p53 tumor suppressor interaction.
Markowitz J; Chen I; Gitti R; Baldisseri DM; Pan Y; Udan R; Carrier F; MacKerell AD; Weber DJ
J Med Chem; 2004 Oct; 47(21):5085-93. PubMed ID: 15456252
[TBL] [Abstract][Full Text] [Related]
2. Small molecules bound to unique sites in the target protein binding cleft of calcium-bound S100B as characterized by nuclear magnetic resonance and X-ray crystallography.
Charpentier TH; Wilder PT; Liriano MA; Varney KM; Zhong S; Coop A; Pozharski E; MacKerell AD; Toth EA; Weber DJ
Biochemistry; 2009 Jul; 48(26):6202-12. PubMed ID: 19469484
[TBL] [Abstract][Full Text] [Related]
3. Structural changes in the C-terminus of Ca2+-bound rat S100B (beta beta) upon binding to a peptide derived from the C-terminal regulatory domain of p53.
Rustandi RR; Baldisseri DM; Drohat AC; Weber DJ
Protein Sci; 1999 Sep; 8(9):1743-51. PubMed ID: 10493575
[TBL] [Abstract][Full Text] [Related]
4. Location of the Zn(2+)-binding site on S100B as determined by NMR spectroscopy and site-directed mutagenesis.
Wilder PT; Baldisseri DM; Udan R; Vallely KM; Weber DJ
Biochemistry; 2003 Nov; 42(46):13410-21. PubMed ID: 14621986
[TBL] [Abstract][Full Text] [Related]
5. Calcium-binding properties of wild-type and EF-hand mutants of S100B in the presence and absence of a peptide derived from the C-terminal negative regulatory domain of p53.
Markowitz J; Rustandi RR; Varney KM; Wilder PT; Udan R; Wu SL; Horrocks WD; Weber DJ
Biochemistry; 2005 May; 44(19):7305-14. PubMed ID: 15882069
[TBL] [Abstract][Full Text] [Related]
6. Solution NMR structure of S100B bound to the high-affinity target peptide TRTK-12.
Inman KG; Yang R; Rustandi RR; Miller KE; Baldisseri DM; Weber DJ
J Mol Biol; 2002 Dec; 324(5):1003-14. PubMed ID: 12470955
[TBL] [Abstract][Full Text] [Related]
7. The effects of CapZ peptide (TRTK-12) binding to S100B-Ca2+ as examined by NMR and X-ray crystallography.
Charpentier TH; Thompson LE; Liriano MA; Varney KM; Wilder PT; Pozharski E; Toth EA; Weber DJ
J Mol Biol; 2010 Mar; 396(5):1227-43. PubMed ID: 20053360
[TBL] [Abstract][Full Text] [Related]
8. The Ca(2+)-dependent interaction of S100B(beta beta) with a peptide derived from p53.
Rustandi RR; Drohat AC; Baldisseri DM; Wilder PT; Weber DJ
Biochemistry; 1998 Feb; 37(7):1951-60. PubMed ID: 9485322
[TBL] [Abstract][Full Text] [Related]
9. Divalent metal ion complexes of S100B in the absence and presence of pentamidine.
Charpentier TH; Wilder PT; Liriano MA; Varney KM; Pozharski E; MacKerell AD; Coop A; Toth EA; Weber DJ
J Mol Biol; 2008 Sep; 382(1):56-73. PubMed ID: 18602402
[TBL] [Abstract][Full Text] [Related]
10. Design of Inhibitors for S100B.
Markowitz J; Mackerell AD; Carrier F; Charpentier TH; Weber DJ
Curr Top Med Chem; 2005; 5(12):1093-108. PubMed ID: 16248785
[TBL] [Abstract][Full Text] [Related]
11. Molecular dynamics simulation of S100B protein to explore ligand blockage of the interaction with p53 protein.
Zhou Z; Li Y
J Comput Aided Mol Des; 2009 Oct; 23(10):705-14. PubMed ID: 19597941
[TBL] [Abstract][Full Text] [Related]
12. Small Molecule Inhibitors of Ca(2+)-S100B Reveal Two Protein Conformations.
Cavalier MC; Ansari MI; Pierce AD; Wilder PT; McKnight LE; Raman EP; Neau DB; Bezawada P; Alasady MJ; Charpentier TH; Varney KM; Toth EA; MacKerell AD; Coop A; Weber DJ
J Med Chem; 2016 Jan; 59(2):592-608. PubMed ID: 26727270
[TBL] [Abstract][Full Text] [Related]
13. Computational screening and design of S100B ligand to block S100B-p53 interaction.
Whitlow JL; Varughese JF; Zhou Z; Bartolotti LJ; Li Y
J Mol Graph Model; 2009; 27(8):969-77. PubMed ID: 19324580
[TBL] [Abstract][Full Text] [Related]
14. The calcium-binding protein S100B down-regulates p53 and apoptosis in malignant melanoma.
Lin J; Yang Q; Wilder PT; Carrier F; Weber DJ
J Biol Chem; 2010 Aug; 285(35):27487-27498. PubMed ID: 20587415
[TBL] [Abstract][Full Text] [Related]
15. A search for inhibitors of S100B, a member of the S100 family of calcium-binding proteins.
Markowitz J; MacKerell AD; Weber DJ
Mini Rev Med Chem; 2007 Jun; 7(6):609-16. PubMed ID: 17584159
[TBL] [Abstract][Full Text] [Related]
16. Theoretical study on binding of S100B protein.
Gieldon A; Mori M; Del Conte R
J Mol Model; 2007 Nov; 13(11):1123-31. PubMed ID: 17713798
[TBL] [Abstract][Full Text] [Related]
17. Fragmenting the S100B-p53 interaction: combined virtual/biophysical screening approaches to identify ligands.
Agamennone M; Cesari L; Lalli D; Turlizzi E; Del Conte R; Turano P; Mangani S; Padova A
ChemMedChem; 2010 Mar; 5(3):428-35. PubMed ID: 20077460
[TBL] [Abstract][Full Text] [Related]
18. Potential conformational heterogeneity of p53 bound to S100B(ββ).
McDowell C; Chen J; Chen J
J Mol Biol; 2013 Mar; 425(6):999-1010. PubMed ID: 23313430
[TBL] [Abstract][Full Text] [Related]
19. Structure of the negative regulatory domain of p53 bound to S100B(betabeta).
Rustandi RR; Baldisseri DM; Weber DJ
Nat Struct Biol; 2000 Jul; 7(7):570-4. PubMed ID: 10876243
[TBL] [Abstract][Full Text] [Related]
20. A novel S100 target conformation is revealed by the solution structure of the Ca2+-S100B-TRTK-12 complex.
McClintock KA; Shaw GS
J Biol Chem; 2003 Feb; 278(8):6251-7. PubMed ID: 12480931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
